Recent investigations have indicated that reducing the infiltration and activity of CD8+ T cells can promote resistance to immunotherapy in bladder cancer,22 whereas mast cell density has been shown to predict lymph node metastasis in patients with breast cancer.23 This evidence concerns the gene CD8A and breast carcinoma.